Compare AbCellera Biologics Inc (ABCL) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs VF Corp — how do they compare? AbCellera Biologics Inc trades at $8.98 (market cap $2.99B), while VF Corp trades at $14.9 (market cap $5.81B). The key difference: VF Corp is the larger of the two by market cap, and VF Corp pays a 2.44% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | VFC | |
|---|---|---|
Market Cap | $2.99B | $5.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $21.55 |
52-Week Low | $2.78 | $12.21 |
Enterprise Value | $2.58B | $10.09B |
Dividend Yield | — | 2.44% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
